Became P.L.2016, c.73, on December 5, 2016.
2016–2017 Session
Senate Bill 2024
Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor from Mar 14
Chief co-sponsor from Mar 14
In the General Assembly
Sponsor from Oct 20
Erik Peterson, Herb Conaway Jr., Raj Mukherji, Daniel R. Benson, Angela V. McKnight
Chief co-sponsors from Oct 20
2 co-sponsors
Its course
April 18 to December 5, 2016, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action8 actions on 6 days
In the SenateApr 18 to Jun 3073 days
Health, Human Services and Senior CitizensApr 18 to May 1628 days
In the General AssemblyJun 30 to Oct 20112 days
Health and Senior ServicesJun 30 to Oct 698 days
With the GovernorOct 20 to Dec 546 days
Votes
Yeas to nays, as the Legislature recorded them. Committee votes are set in.
Senate, third reading40–0
Passed · Jun 30
General Assembly, third reading73–0
Passed · Oct 20
Text
Each version as the Legislature printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislature published it is below.
In the Senate Apr 18 – Jun 30
- Apr 18Introduced in the Senate and sent to Health, Human Services and Senior Citizens
- May 16Health, Human Services and Senior Citizens recommended it
- Read a second time
- Jun 30Passed the Senate, 40 to 0
In the General Assembly Jun 30 – Oct 20
- Jun 30Arrived in the General Assembly
- Sent to Health and Senior Services
- Oct 6Health and Senior Services recommended it
- Read a second time
- Oct 20Passed the General Assembly, 73 to 0, and so both houses
To the Governor Dec 5
- Dec 5Signed by the Governor
- Became P.L.2016, c.73